The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.
Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Eczema Resources for Your Patients: Week 1
SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall
2 Clarke Drive Cranbury, NJ 08512